Stocktoria
Viridian Therapeutics, Inc.DE VRDN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-06-18
Viridian Therapeutics, Inc.DE institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,773,622 | $62.1M | 4.69% |
| Point72 Asset Management, L.P. | 2,356,208 | $43.3M | 2.31% |
| D. E. Shaw & Co., Inc. | 1,182,222 | $21.7M | 1.16% |
| RENAISSANCE TECHNOLOGIES LLC | 768,600 | $14.1M | 0.75% |
| CITADEL ADVISORS LLC | 211,603 | $3.9M | 0.21% |
| AQR CAPITAL MANAGEMENT LLC | 127,301 | $2.3M | 0.13% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.